Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle?

অনুযায়ী Passiglia, Francesco, Novello, Silvia
প্রকাশিত Ann Transl Med (2018)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?

অনুযায়ী Passiglia, Francesco, Novello, Silvia
প্রকাশিত Transl Lung Cancer Res (2020)

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?

অনুযায়ী Bironzo, Paolo, Passiglia, Francesco, Novello, Silvia
প্রকাশিত Ann Transl Med (2019)

Moving osimertinib to first-line: the right “strategy” in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?

অনুযায়ী Passiglia, Francesco, Raez, Luis E., Rolfo, Christian
প্রকাশিত J Thorac Dis (2018)

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer?

অনুযায়ী Passiglia, Francesco, Bironzo, Paolo, Scagliotti, Giorgio V.
প্রকাশিত Transl Lung Cancer Res (2019)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

অনুযায়ী Passiglia, Francesco, Reale, Maria Lucia, Cetoretta, Valeria, Novello, Silvia
প্রকাশিত Immunotargets Ther (2021)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience

অনুযায়ী Capelletto, Enrica, Passiglia, Francesco, Ferraresi, Federica, Vallone, Stefania, Novello, Silvia
প্রকাশিত J Thorac Dis (2020)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review

অনুযায়ী Leone, Gianmarco, Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Novello, Silvia
প্রকাশিত Transl Lung Cancer Res (2020)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

অনুযায়ী Passiglia, Francesco, Cetoretta, Valeria, De Filippis, Marco, Napoli, Valerio, Novello, Silvia
প্রকাশিত Transl Lung Cancer Res (2021)

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

অনুযায়ী Thungappa, Satheesh, Ferri, Jose, Caglevic, Christian, Passiglia, Francesco, Raez, Luis, Rolfo, Christian
প্রকাশিত ESMO Open (2017)

Vaccine and immune cell therapy in non-small cell lung cancer

অনুযায়ী Oliveres, Helena, Caglevic, Christian, Passiglia, Francesco, Taverna, Simona, Smits, Evelien, Rolfo, Christian
প্রকাশিত J Thorac Dis (2018)

Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway

অনুযায়ী La Paglia, Laura, Listì, Angela, Caruso, Stefano, Amodeo, Valeria, Passiglia, Francesco, Bazan, Viviana, Fanale, Daniele
প্রকাশিত PPAR Res (2017)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

অনুযায়ী Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
প্রকাশিত Front Med (Lausanne) (2017)

Multisciplinary management of patients with liver metastasis from colorectal cancer

অনুযায়ী De Greef, Kathleen, Rolfo, Christian, Russo, Antonio, Chapelle, Thiery, Bronte, Giuseppe, Passiglia, Francesco, Coelho, Andreia, Papadimitriou, Konstantinos, Peeters, Marc
প্রকাশিত World J Gastroenterol (2016)

Nintedanib in NSCLC: evidence to date and place in therapy

অনুযায়ী Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
প্রকাশিত Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

অনুযায়ী Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
প্রকাশিত Oncotarget (2016)

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

অনুযায়ী Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
প্রকাশিত Sci Rep (2018)

Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

অনুযায়ী Passiglia, Francesco, Rizzo, Sergio, Di Maio, Massimo, Galvano, Antonio, Badalamenti, Giuseppe, Listì, Angela, Gulotta, Leonardo, Castiglia, Marta, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio
প্রকাশিত Sci Rep (2018)

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

অনুযায়ী Bronte, Giuseppe, Silvestris, Nicola, Castiglia, Marta, Galvano, Antonio, Passiglia, Francesco, Sortino, Giovanni, Cicero, Giuseppe, Rolfo, Christian, Peeters, Marc, Bazan, Viviana, Fanale, Daniele, Giordano, Antonio, Russo, Antonio
প্রকাশিত Oncotarget (2015)

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

অনুযায়ী Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
প্রকাশিত Ther Adv Med Oncol (2019)